
The Return of the ‘Debasement Trade’
By THE NEW YORK SUN
|The National Health Service said Friday that ‘outside of a research setting, puberty suppressing hormones should not be routinely commissioned for children and adolescents.’

LONDON — The publicly funded health service in England has decided it will not routinely offer puberty-blocking drugs to children at gender identity clinics, saying more evidence is needed about the potential benefits and harms.

By THE NEW YORK SUN
|
By THE NEW YORK SUN
|
By MATTHEW RICE
|
By BENNY AVNI
|
By GEORGE WILL
|
By ROSS ANDERSON
|
By JEFFREY WELLS
|
By MATTHEW RICE
|LONDON — The publicly funded health service in England has decided it will not routinely offer puberty-blocking drugs to children at gender identity clinics, saying more evidence is needed about the potential benefits and harms.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.